Clinical trial
Multi-Centre Prospective Randomized Study on the Use of Two Different Doses of Rabbit Anti-Thymocyte Globulin for GVHD Prevention in Paediatric Patients With Haematological Malignancies Given an Unrelated Donor Haematopoietic Stem Cell Transplantation
NCT00934557 is registered in ClinicalTrials.gov with Fondazione IRCCS Policlinico San Matteo di Pavia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-Centre Prospective Randomized Study on the Use of Two Different Doses of Rabbit Anti-Thymocyte Globulin for GVHD Prevention in Paediatric Patients With Haematological Malignancies Given an Unrelated Donor Haematopoietic Stem Cell Transplantation
- Lead sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- March 31, 2008
- Completion date
- Not reported
- Enrollment
- 42
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
paediatric patients affected by haematological malignancies and eligible to undergo hsct from an unrelated volunteer